Rivercell
Rivercell builds experimental data infrastructure and AI models to predict how human cells respond to treatments.
$25MSeed
ParticipantA
Alven
Activity from announced rounds
Activity in this selectionFrance
Alven is an investment firm whose own news covers Archy’s Series C and which Attention identifies as a returning investor.
Recorded funding activity
Archy combines dental-practice operations and clinical software with AI tools for routine administrative work. Attention develops agents for revenue-team workflows. The recorded history also includes Generare, which produces molecular data for drug development. These company-level events connect Alven’s attribution across distinct business applications.
- Rounds participated in
- 6
- Confirmed lead rounds
- 0 5 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $179.2M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionGenerare
Generates molecular data for drug development
€20MSeries A
Role not disclosedKestra
Provides open-source orchestration platform unifying data, AI, infrastructure and business workflows
$25MSeries A
Role not disclosedCryptio
Provides accounting and reporting software for digital asset businesses
$45MSeries B
Role not disclosedVerley
Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers
€32MSeries A
Role not disclosedStoïk
Stoïk combines cyber insurance with active cyber-risk prevention.
€20MSeries C
Role not disclosed